Tocilizumab-Associated Small Bowel Perforation in a Young Patient With Rheumatoid Arthritis: A Lesson to Remember During COVID-19 Pandemic

Tocilizumab is a recombinant humanized monoclonal antibody directed against the interleukin-6 (IL-6) receptor, which has been used for the treatment of rheumatoid arthritis (RA). A range of side effects have been associated with tocilizumab, with gastrointestinal perforation (GIP) being described as...

Descripción completa

Detalles Bibliográficos
Autores principales: Saad, Eltaib, Awadelkarim, Abdalaziz, Agab, Mohamed, Babkir, Akram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8929210/
https://www.ncbi.nlm.nih.gov/pubmed/35356392
http://dx.doi.org/10.14740/jmc3902

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8929210/
https://www.ncbi.nlm.nih.gov/pubmed/35356392
http://dx.doi.org/10.14740/jmc3902

Ejemplares similares